Marie Thibault
Stock Analyst at BTIG
(3.73)
# 776
Out of 5,111 analysts
102
Total ratings
47.87%
Success rate
9.29%
Average return
Main Sectors:
Stocks Rated by Marie Thibault
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CBLL CeriBell | Reiterates: Buy | $30 | $21.90 | +36.99% | 1 | Dec 15, 2025 | |
| EW Edwards Lifesciences | Maintains: Buy | $100 → $103 | $83.38 | +23.53% | 2 | Dec 5, 2025 | |
| MASI Masimo | Maintains: Buy | $198 → $200 | $137.40 | +45.56% | 7 | Dec 4, 2025 | |
| HAE Haemonetics | Reiterates: Buy | $88 | $80.40 | +9.45% | 3 | Nov 21, 2025 | |
| BSX Boston Scientific | Reiterates: Buy | $132 | $92.19 | +43.18% | 14 | Nov 21, 2025 | |
| PODD Insulet | Maintains: Buy | $370 → $380 | $291.51 | +30.36% | 6 | Nov 21, 2025 | |
| ABT Abbott Laboratories | Reiterates: Buy | $145 | $128.47 | +12.87% | 14 | Nov 20, 2025 | |
| KMTS Kestra Medical Technologies | Initiates: Buy | $32 | $26.48 | +20.85% | 1 | Nov 18, 2025 | |
| OM Outset Medical | Maintains: Buy | $39 → $17 | $3.97 | +328.21% | 1 | Nov 11, 2025 | |
| ARAY Accuray | Maintains: Buy | $5 → $4 | $1.05 | +280.95% | 2 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $10.08 | +128.17% | 4 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $109 → $85 | $65.73 | +29.32% | 8 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $195 → $215 | $169.00 | +27.22% | 8 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.19 | - | 1 | Oct 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $11.93 | +109.56% | 3 | Sep 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $4.30 | - | 2 | Aug 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $58 → $52 | $41.04 | +26.71% | 7 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $62 → $65 | $72.03 | -9.76% | 8 | Oct 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.01 | - | 2 | Jun 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.67 | - | 3 | Oct 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.76 | - | 3 | Oct 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $6.79 | - | 1 | Jan 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $6 | $363.25 | -98.35% | 1 | Apr 9, 2020 |
CeriBell
Dec 15, 2025
Reiterates: Buy
Price Target: $30
Current: $21.90
Upside: +36.99%
Edwards Lifesciences
Dec 5, 2025
Maintains: Buy
Price Target: $100 → $103
Current: $83.38
Upside: +23.53%
Masimo
Dec 4, 2025
Maintains: Buy
Price Target: $198 → $200
Current: $137.40
Upside: +45.56%
Haemonetics
Nov 21, 2025
Reiterates: Buy
Price Target: $88
Current: $80.40
Upside: +9.45%
Boston Scientific
Nov 21, 2025
Reiterates: Buy
Price Target: $132
Current: $92.19
Upside: +43.18%
Insulet
Nov 21, 2025
Maintains: Buy
Price Target: $370 → $380
Current: $291.51
Upside: +30.36%
Abbott Laboratories
Nov 20, 2025
Reiterates: Buy
Price Target: $145
Current: $128.47
Upside: +12.87%
Kestra Medical Technologies
Nov 18, 2025
Initiates: Buy
Price Target: $32
Current: $26.48
Upside: +20.85%
Outset Medical
Nov 11, 2025
Maintains: Buy
Price Target: $39 → $17
Current: $3.97
Upside: +328.21%
Accuray
Nov 6, 2025
Maintains: Buy
Price Target: $5 → $4
Current: $1.05
Upside: +280.95%
Nov 4, 2025
Reiterates: Buy
Price Target: $23
Current: $10.08
Upside: +128.17%
Oct 31, 2025
Maintains: Buy
Price Target: $109 → $85
Current: $65.73
Upside: +29.32%
Oct 31, 2025
Maintains: Buy
Price Target: $195 → $215
Current: $169.00
Upside: +27.22%
Oct 20, 2025
Downgrades: Neutral
Price Target: n/a
Current: $2.19
Upside: -
Sep 5, 2025
Reiterates: Buy
Price Target: $25
Current: $11.93
Upside: +109.56%
Aug 20, 2025
Downgrades: Neutral
Price Target: n/a
Current: $4.30
Upside: -
Apr 30, 2025
Maintains: Buy
Price Target: $58 → $52
Current: $41.04
Upside: +26.71%
Oct 14, 2024
Maintains: Buy
Price Target: $62 → $65
Current: $72.03
Upside: -9.76%
Jun 25, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.01
Upside: -
Oct 6, 2023
Downgrades: Neutral
Price Target: n/a
Current: $1.67
Upside: -
Oct 13, 2021
Downgrades: Neutral
Price Target: n/a
Current: $1.76
Upside: -
Jan 21, 2021
Downgrades: Neutral
Price Target: n/a
Current: $6.79
Upside: -
Apr 9, 2020
Maintains: Buy
Price Target: $11 → $6
Current: $363.25
Upside: -98.35%